SCHEMBL8139983

SCHEMBL8139983

CCCCCC(CC(=O)Nc1cc(C(=O)NC)ccc1C(C)(C)C)c1ccc(OCc2ccccc2)cc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.40
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MRGPRX4 Q96LA9 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
LNPEP Q9UIQ6 2/20 0.37
ERAP2 Q6P179 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MET P08581 1/20 0.37
SMPD1 P17405 1/20 0.36
EGFR P00533 1/20 0.36
ERBB2 P04626 1/20 0.36
ERBB4 Q15303 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8128720 0.93 LNPEP (0.43) MAPTMEN1KMT2AMRGPRX4LNPEP
SCHEMBL8134752 0.92 LNPEP (0.38) MAPTMEN1KMT2AMRGPRX4LNPEP
SCHEMBL8135122 0.92 HDAC1 (0.40) MAPTMEN1KMT2AHDAC1HDAC8
SCHEMBL8148216 0.90 LPAR1 (0.41) MAPTHDAC1HDAC8HDAC6KDM4E
SCHEMBL8133459 0.89 MAPK1 (0.38) MAPTHDAC1HDAC8HDAC6MMP3
SCHEMBL8134646 0.89 LPAR1 (0.40) MAPTHDAC1HDAC8HDAC6MMP2
SCHEMBL8142291 0.89 HDAC1 (0.35) MAPTMEN1KMT2AHDAC1HDAC8
SCHEMBL8141778 0.88 BRD4 (0.40) BRD4MAPTMEN1KMT2AHDAC1
SCHEMBL8148224 0.88 ALDH1A1 (0.38) MAPTHDAC1HDAC8HDAC6SMPD1
SCHEMBL8140040 0.88 LPAR1 (0.41) MAPTMEN1KMT2AHDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763524-B1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO CO (JP) 2000-08-23 EP disclosed
US-6040339-A TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA OR ARTERIOSCLEROSIS IN A MAMMAL SANKYO COMPANY, LIMITED (JP) 2000-03-21 US disclosed
US-5880147-A Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use SANKYO COMPANY, LIMITED (JP) 1999-03-09 US disclosed
EP-0763524-A1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO COMPANY LIMITED (JP) 1997-03-19 EP disclosed